Similar Articles
Hopelessness, Depression and Life Satisfaction Among The Patients With Multiple Sclerosis
Güler Duru Aşiret, Leyla Özdemir, Naile Maraşlıoğlu
DOI: 10.4274/Tnd.24471
Injection Administration Features of the Patients who self-administer Subcutaneous Immunomodulator Injection and the Injection Site Reactions
Tülay Başak, Şeref Demirkaya, Şenay Uzun
DOI: 10.4274/Tnd.15010
Peduncular Hallucinosis Due to Multiple Sclerosis: A Case Report
Özden Kamışlı, Yüksel Kaplan, Suat Kamışlı, Cemal Özcan
DOI: 10.4274/Tnd.05658
Sjögren Syndrome Which Simulates Relapsing Remitting Multiple Sclerosis Clinical Features: Case Report
Haluk Gümüş, Zehra Akpınar
DOI: 10.4274/Tnd.12599
Management of Multiple Sclerosis patient in special conditions
Ayşe Altıntaş, Uğur Uygunoğlu, Burcu Zeydan, Tülin Coşkun
DOI: 10.4274/Tnd.66487
Assessment of Early Stage Non-Motor Symptoms in Parkinson’sDisease
Haluk Gümüş, Zehra Akpınar, Orhan Demir
DOI: 10.4274/Tnd.58672
Epileptic Seizures in Multiple Sclerosis Patients
Kamber Zeqiraj, Nexhat Shatri, Jera Kruja, Afrim Blyta, Enver Isaku, Nazim Dakaj
DOI: 10.4274/Tnd.46362
Screening for Cognitive Impairment in Multiple Sclerosis with MOCA Test
Selma Aksoy, Emin Timer, Sibel Mumcu, Mücella Akgün, Elif Kırak, Dilek Necioğlu Örken
DOI: 10.4274/Tnd.86570
Does Ability to Identify Odours Differ Among Clinical Subtypes of Parkinson’s Disease?
Hakan Tekeli, Mustafa Tansel Kendirli, Mehmet Güney Şenol, Richard L. Doty
DOI: 10.4274/Tnd.50455
Determining the Frequency of Depression and Cognitive Dysfunction in Patients with Multiple Sclerosis
Emine Bilgi, Hasan Hüseyin Özdemir, Serpil Bulut
DOI: 10.4274/Tnd.15045
Does Ability to Identify Odors Differ Among Clinical Subtypes of Parkinson's Disease?
Tuba Aydemir Özcan, Serkan Özben, Hüsniye Aylin Hakyemez, Mithat Bedir, Emel Oğuz Akarsu, Feriha Özer, Lütfü Hanoğlu, Gülüm Ivgin Bayraktar
DOI: 10.4274/Tnd.79069
Malignant Syndrome in a Patient with Parkinson's Disease
Nesrin Helvacı Yılmaz, Gökçen Duymaz, Mehmet Akif Yaşar
DOI: 10.4274/Tnd.39358
Is fatigue related to temperament and character dimansions in patients with multiple sklerozis?
Suzan Üstün, Sadullah Sağlam, Sema Sağlam, Murat Kuloğlu, Serpil Bulut
DOI: 10.4274/Tnd.60024
Mitoxantrone in the treatment of multiple sclerosis: a single-center experience
Özlem Taşkapılıoğlu, Deniz Kamacı Şener, Aslı Bahar Turan, Şükran Yurtoğulları, Ahmet Tütüncü, Sümeyye Güllülü, Gökhan Ocakoğlu, Ömer Faruk Turan
DOI: 10.4274/Tnd.38039
Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
Özlem Taşkapılıoğlu, Aslı Bahar Turan, Murat Albas, Ömer Faruk Turan
DOI: 10.4274/Tdn.64325
Sjögren's Syndrome Presenting with Epileptic Seizure: Case Report
Emine Rabia Koç, Ülkühan Düzgün, Alevtina Ersoy, Atilla İlhan
DOI: 10.4274/Tnd.48992
Investigation of Mean Platelet Volume in Patients with Multiple Sclerosis
Ertuğrul Uzar, Adalet Arıkanoğlu, Yavuz Yücel, Birsen Aydın, Mehmet Halis Tanrıverdi, Nebahat Taşdemir
Cranial Neuropathy in Multiple Sclerosis
Mine Hayriye Sorgun, Bilge Koçer, Funda Kaplan, Nesrin Yılmaz, Nezih Yücemen, Canan Yücesan
Visual Hallucination, Visual Evoked Potentials and Cognitive Dysfunction in Idiopathic Parkinson’s Disease
Tuba Aydemir Özcan, Feriha Özer, Hürtan Acar, Sibel Çetin, Serkan Özben, Gülsün Çınarlı Gül
Diplopia Associated with Interferon-b1a Treatment: Report of a Case
Özge Saraç